Clinical Trial Update: Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for bevacizumab plus paclitaxel with maintenance endocrine therapy in metastatic breast cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Japan Breast Cancer Research Group | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED